CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Crohn's Disease
Related studies linked through entity extraction aliases.
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access to Risankizumab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)
- Status
- COMPLETED
- Phase
- N/A
Assessment of Nutritional Status of Patients With Crohn's Disease
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation
- Status
- TERMINATED
- Phase
- PHASE2
Exclusive Enteral Nutrition and Corticosteroids Therapy in Crohn's Disease (EENCD)
- Status
- TERMINATED
- Phase
- PHASE4
Relationship Between Prophylactic Drainage and Postoperative Complications (PPOI) in Crohn's Patients After Surgery
- Status
- UNKNOWN
- Phase
- NA
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Cell Surface Marker Expression in Autoimmune Diseases
- Status
- COMPLETED
- Phase
- N/A
A Study of E6011 in Participants With Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
- Status
- UNKNOWN
- Phase
- N/A
Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease
- Status
- UNKNOWN
- Phase
- NA
A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study
- Status
- COMPLETED
- Phase
- N/A
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of an Online Therapeutic Education Program for Patients With Inflammatory Bowel Disease
- Status
- UNKNOWN
- Phase
- NA
Efficacy and Safety of TD-1473 in Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2